D'Antoni ML, Andreatta K, Acosta R, Martin H, et al. Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) Efficacy in Participants with Pre-existing Primary Integrase Inhibitor Resistance Through 48 Weeks of Phase 3 Clinical Trials. J Acquir Immune Defic Syndr 2021 Dec 10. pii: 00126334-900000000-95741.
PMID: 34897227